Clinical Trials Insight: 700032402

Trial Profile

Clinical Trials Insight: 700032402

Recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Jul 2010

At a glance

  • Drugs Nerve growth factor (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors NsGene
  • Most Recent Events

    • 14 Jul 2010 Preliminary results from this trial have been reported at the 2010 International Conference on Alzheimer's Disease.
    • 10 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top